Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
NCT04539951

Pragmatic Trial of Obsessive-compulsive Disorder

Led by Shanghai Mental Health Center · Updated on 2025-05-15

1600

Participants Needed

1

Research Sites

431 weeks

Total Duration

On this page

Sponsors

S

Shanghai Mental Health Center

Lead Sponsor

T

The first specialized hospital of harbin

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study includes a sequenced clinical trial in order to assess the efficacy of several switching or augment strategies when initial treatment is ineffective,and to provide strong evidence for clinical practice and international guidelines for Obsessive-Compulsive Disorder treatments.

CONDITIONS

Official Title

Pragmatic Trial of Obsessive-compulsive Disorder

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Meet DSM-5 diagnostic criteria for OCD as the primary diagnosis
  • Age between 18 and 65 years
  • Score at least 20 on Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
  • Have never received medication for OCD
  • Have not received any psychotherapy for OCD in the past 1 month
  • Provided written informed consent
Not Eligible

You will not qualify if you...

  • Diagnosed with Schizophrenia Spectrum or other psychotic disorders, or Bipolar and related disorders
  • Have moderate or higher suicide risk (≥9 on MINI Suicide Module)
  • Severe substance use in the past year that may affect treatment adherence
  • Severe depression with Beck Depression Inventory (BDI) score of 29 or higher
  • Comorbid psychiatric or medical disorders affecting medication adherence or efficacy (e.g., borderline personality disorder, CNS disorders)
  • Pregnant or lactating females

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China, 200030

Actively Recruiting

Loading map...

Research Team

Z

Zhen Wang, PhD,MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here